1. |
Seaworth BJ, Griffith DE. Therapy of multidrug-resistant and extensively drug-resistant tuberculosis. Microbiol Spectr, 2017, 5(2): 1-2.
|
2. |
曾瑜, 杨晓妍, 周海龙, 等. 中国人群结核病疾病负担的系统评价. 中国循证医学杂志, 2018, 18(6): 570-579.
|
3. |
李瑜琴, 向敏, 陈玲, 等. 2013-2016 年遵义地区 870 例肺结核患者耐药状况分析. 中国防痨杂志, 2018, 40(6): 604-608.
|
4. |
张良基, 刘建南, 林立, 等. 不同诊断方法对结核性胸膜炎诊断价值对比. 中外医疗, 2017, (13): 28-30.
|
5. |
Patil CB, Dixit R, Gupta R. Thoracoscopic evaluation of 129 cases having undiagnosed exudative pleural effusions. Lung India, 2016, 33(5): 502-506.
|
6. |
Zhou X, Jiang P, Huan X, et al. Ultrasound-guided versus thoracoscopic pleural biopsy for diagnosing tuberculous pleurisy following inconclusive thoracentesis: a randomized, controlled trial. Med Sci Monit, 2018, 10(24): 7238-7248.
|
7. |
Edi ZM, Kadhem SBr, Jumaa MG. Molecular detection of RIF resistance in pulmonary and extrapulmonary specimens in Misan province-South of Iraq. Indian J Public Health Res Dev, 2019, 10(6): 797-800.
|
8. |
Saeed M, Ahmad M, Iram S. GeneXpert technology. A breakthrough for the diagnosis of tuberculous pericarditis and pleuritis in less than 2 hours. Saudi Med J, 2017, 38(7): 699-705.
|
9. |
陈效友. 《结核病分类》与《肺结核诊断》卫生行业新标准中关于结核性胸膜炎的解析. 中国防痨杂志, 2018, 40(3): 239-241.
|
10. |
中国恶性胸腔积液诊断与治疗专家共识组. 恶性胸腔积液诊断与治疗专家共识. 中华内科杂志, 2014, 53(3): 252-255.
|
11. |
唐晓媛, 左慧敏, 陈国峰, 等. 内科胸腔镜治疗结核性胸膜炎的意义. 中国内镜杂志, 2018, 24(7): 1-4.
|
12. |
唐书福, 刘权贤, 张建勇, 等. 胸腔镜联合胸水 gene-Xpert 在结核性胸膜炎中的诊断评价. 中华医院感染学杂志, 2018, 28(22): 3434-3437.
|
13. |
Prakash AK, Datta B, Tripathy JP. The clinical utility of cycle of threshold value of GeneXpert MTB/RIF (CBNAAT) and its diagnostic accuracy in pulmonary and extra-pulmonary samples at a tertiary care center in India. Indian J Tuberc, 2018, 65(4): 296-302.
|